Simplified interpretative format for assessing test interference: Studies with hemoglobin-based oxygen carrier solutions

Steven (Steve) Kazmierczak, Paul G. Catrou, Donald Boudreau

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Substances such as hemoglobin that interfere with analytical processes are recognized as a frequent source of error in laboratory medicine. Standard guidelines for assessment of test interferences assume that interference effects are not related to the concentration of the analyte being measured. However, previous investigations have demonstrated that interference effects can be markedly different, depending on the concentrations of interferent and analyte within the specimen. An experimental protocol for investigating these different types of interference effects has been developed. This protocol utilizes an orthogonally arranged matrix with progressively increasing concentrations of analyte and interferent. Evaluation of the measured analyte concentrations in specimens within the matrix using multiple regression analysis allows the magnitude, direction, and significance of each type of interference to be determined. Unfortunately, implementation of the interference data derived from the multiple regression analysis for judging the clinical acceptability of test results when an interferent is present is difficult. We describe a two-dimensional graphical format for evaluating the clinical acceptability of test results, based on criteria established under the Clinical Laboratory Improvement Amendments of 1988, in specimens containing hemoglobin-based oxygen carrier solutions.

Original languageEnglish (US)
Pages (from-to)2347-2352
Number of pages6
JournalClinical Chemistry
Volume44
Issue number11
StatePublished - 1998
Externally publishedYes

Fingerprint

Regression analysis
Hemoglobins
Regression Analysis
Clinical laboratories
Oxygen
Medicine
Research Design
Guidelines
Direction compound

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Simplified interpretative format for assessing test interference : Studies with hemoglobin-based oxygen carrier solutions. / Kazmierczak, Steven (Steve); Catrou, Paul G.; Boudreau, Donald.

In: Clinical Chemistry, Vol. 44, No. 11, 1998, p. 2347-2352.

Research output: Contribution to journalArticle

@article{f1dff4fb722d46189083708afa8be211,
title = "Simplified interpretative format for assessing test interference: Studies with hemoglobin-based oxygen carrier solutions",
abstract = "Substances such as hemoglobin that interfere with analytical processes are recognized as a frequent source of error in laboratory medicine. Standard guidelines for assessment of test interferences assume that interference effects are not related to the concentration of the analyte being measured. However, previous investigations have demonstrated that interference effects can be markedly different, depending on the concentrations of interferent and analyte within the specimen. An experimental protocol for investigating these different types of interference effects has been developed. This protocol utilizes an orthogonally arranged matrix with progressively increasing concentrations of analyte and interferent. Evaluation of the measured analyte concentrations in specimens within the matrix using multiple regression analysis allows the magnitude, direction, and significance of each type of interference to be determined. Unfortunately, implementation of the interference data derived from the multiple regression analysis for judging the clinical acceptability of test results when an interferent is present is difficult. We describe a two-dimensional graphical format for evaluating the clinical acceptability of test results, based on criteria established under the Clinical Laboratory Improvement Amendments of 1988, in specimens containing hemoglobin-based oxygen carrier solutions.",
author = "Kazmierczak, {Steven (Steve)} and Catrou, {Paul G.} and Donald Boudreau",
year = "1998",
language = "English (US)",
volume = "44",
pages = "2347--2352",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "11",

}

TY - JOUR

T1 - Simplified interpretative format for assessing test interference

T2 - Studies with hemoglobin-based oxygen carrier solutions

AU - Kazmierczak, Steven (Steve)

AU - Catrou, Paul G.

AU - Boudreau, Donald

PY - 1998

Y1 - 1998

N2 - Substances such as hemoglobin that interfere with analytical processes are recognized as a frequent source of error in laboratory medicine. Standard guidelines for assessment of test interferences assume that interference effects are not related to the concentration of the analyte being measured. However, previous investigations have demonstrated that interference effects can be markedly different, depending on the concentrations of interferent and analyte within the specimen. An experimental protocol for investigating these different types of interference effects has been developed. This protocol utilizes an orthogonally arranged matrix with progressively increasing concentrations of analyte and interferent. Evaluation of the measured analyte concentrations in specimens within the matrix using multiple regression analysis allows the magnitude, direction, and significance of each type of interference to be determined. Unfortunately, implementation of the interference data derived from the multiple regression analysis for judging the clinical acceptability of test results when an interferent is present is difficult. We describe a two-dimensional graphical format for evaluating the clinical acceptability of test results, based on criteria established under the Clinical Laboratory Improvement Amendments of 1988, in specimens containing hemoglobin-based oxygen carrier solutions.

AB - Substances such as hemoglobin that interfere with analytical processes are recognized as a frequent source of error in laboratory medicine. Standard guidelines for assessment of test interferences assume that interference effects are not related to the concentration of the analyte being measured. However, previous investigations have demonstrated that interference effects can be markedly different, depending on the concentrations of interferent and analyte within the specimen. An experimental protocol for investigating these different types of interference effects has been developed. This protocol utilizes an orthogonally arranged matrix with progressively increasing concentrations of analyte and interferent. Evaluation of the measured analyte concentrations in specimens within the matrix using multiple regression analysis allows the magnitude, direction, and significance of each type of interference to be determined. Unfortunately, implementation of the interference data derived from the multiple regression analysis for judging the clinical acceptability of test results when an interferent is present is difficult. We describe a two-dimensional graphical format for evaluating the clinical acceptability of test results, based on criteria established under the Clinical Laboratory Improvement Amendments of 1988, in specimens containing hemoglobin-based oxygen carrier solutions.

UR - http://www.scopus.com/inward/record.url?scp=0031789217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031789217&partnerID=8YFLogxK

M3 - Article

C2 - 9799763

AN - SCOPUS:0031789217

VL - 44

SP - 2347

EP - 2352

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 11

ER -